CUSIP: 35803L108
Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,012,928
-
Share change
-
-2,385,984
-
Total reported value
-
$2,519,509
-
Put/Call ratio
-
105%
-
Price per share
-
$0.50
-
Number of holders
-
40
-
Value change
-
-$9,670,825
-
Number of buys
-
19
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 35803L108?
CUSIP 35803L108 identifies FREQ - FREQUENCY THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2023
-
Previous quarter:
Q4 2022
Recent filing periods for CUSIP 35803L108:
Institutional Holders of FREQUENCY THERAPEUTICS INC - COM (FREQ) as of Q1 2023
As of 31 Mar 2023,
FREQUENCY THERAPEUTICS INC - COM (FREQ) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,012,928 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, SIMPLEX TRADING, LLC, and Waldron Private Wealth LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.